Enquiry/Quote

Oncology Cancer Care

Trusted pharma products in Oncology Cancer Care

RITUXIMAB

Strength: 100mg

Form: Infusion

Reference Brands:

View Details Get Enquiry

Rituximab

Strength: IV infusion: 100 mg/10 mL, 500 mg/50 mL; SQ: 1400 mg/11 mL

Form: IV Infusion; Subcutaneous

Reference Brands: Rituxan®(US), MabThera®, Truxima®(EU);Ruxience®(US)

View Details Get Enquiry

Romidepsin

Strength: 10 mg

Form: Injection

Reference Brands: Istodax (USA/EU)

View Details Get Enquiry

Rucaparib Camsylate

Strength: 200 mg

Form: Tablet

Reference Brands:

View Details Get Enquiry

Rucaparib Camsylate

Strength: 200 mg, 250 mg, 300 mg

Form: Oral tablets

Reference Brands: Rubraca® (EU & US)

View Details Get Enquiry

Selpercatinib

Strength: 40 mg, 80 mg, 160 mg

Form: Capsules

Reference Brands: Retevmo (USA)

View Details Get Enquiry

Sonidegib

Strength: 200 mg

Form: Capsules

Reference Brands: Odomzo (USA/EU)

View Details Get Enquiry

Sorafenib

Strength: 200 mg

Form: Tablet

Reference Brands: Nexavar (US & EU)

View Details Get Enquiry

Sotorasib

Strength: 960 mg

Form: Tablets

Reference Brands: Lumakras (USA/EU)

View Details Get Enquiry

Sunitinib

Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg

Form: Tablet

Reference Brands: Sutent® (EU & US)

View Details Get Enquiry

Tacrolimus Tablet

Strength: IR:0.5 mg, 1 mg , 5 mg; ER: 0.5 mg, 1 mg, 3 mg, 5 mg

Form: Tablets

Reference Brands: US: Prograf IR, Astagraf XL; EU: Prograf,Advagraf(PR)

View Details Get Enquiry

Tafasitamab‑cxix

Strength: 200 mg

Form: Injection

Reference Brands: Monjuvi (USA), Minjuvi (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.